Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 6/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MMP14 | P50281 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CHAT | P28329 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL193696 | 0.99 | ACP3 (0.40) | ACP3CA12CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL6442994 | 0.80 | MEN1 (0.32) | ALDH1A1 | |
| SCHEMBL12715301 | 0.79 | ALDH1A1 (0.40) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL600629 | 0.78 | ACP3 (0.38) | ACP3MMP2MMP9ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2258374 | 0.78 | ACP3 (0.39) | ACP3CA2PTK2BL3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL602419 | 0.78 | SLC22A12 (0.32) | — | |
| SCHEMBL6030921 | 0.77 | ACP3 (0.40) | ACP3CA12CA2MMP2MMP9 | |
| Hydrochloric Acid SCHEMBL2464559 | 0.77 | ALDH1A1 (0.39) | CHATALDH1A1 | |
| SCHEMBL1226951 | 0.77 | MEN1 (0.39) | ACP3ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2259611 | 0.76 | ACP3 (0.40) | ACP3CA12CA2MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060110638-A1 | Electrochromic compounds | NTERA LIMITED (IE) | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060110638-A1 | Electrochromic compounds | ETV6, HCN2, EED | ACP3 2868/4885CA12 405/4885CA2 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.